| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 01/26/2012 | US20120020904 Novel proteasome-activating lightening peptides and compositions containing same |
| 01/26/2012 | US20120020881 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes |
| 01/26/2012 | CA2803948A1 Tubulysin analogues |
| 01/25/2012 | EP2409988A2 Peptide fragments for inducing synthesis of extracellular matrix proteins |
| 01/25/2012 | EP2409985A2 Inhibitors de serine proteases, especially of the NS3 protease of the hepatitis C virus |
| 01/25/2012 | EP2409984A1 Dimeric IAP Antagonists |
| 01/25/2012 | EP2409983A1 Tubulysin analogues |
| 01/25/2012 | EP2408802A1 Cyclic amino acid molecules and methods of preparing the same |
| 01/25/2012 | EP2408801A1 Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions |
| 01/25/2012 | EP2408758A1 Crystalline tripeptide epoxy ketone protease inhibitors |
| 01/25/2012 | EP2408445A1 Gold (iii) complexes with oligopeptides functionalized with sulfur donors and use thereof as antitumor agents |
| 01/25/2012 | EP2114924B1 Co-crystals and pharmaceutical compositions comprising the same |
| 01/25/2012 | EP1687018B1 Hepatitis c virus inhibitors |
| 01/25/2012 | EP1545613B9 Auristatin conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 01/25/2012 | CN102329372A Method for preparing peptide aldehyde |
| 01/25/2012 | CN102329371A Method for separating single stereoisomer of Argatroban and polymorphic substance |
| 01/25/2012 | CN102329370A Method for preparing reduced glutathione monosodium salts |
| 01/25/2012 | CN102329246A Multiple-target-point tamibarotene derivatives, preparation method and purposes thereof |
| 01/25/2012 | CN101906137B Conjugate of Arg-Gly-Asp chain and two fatty alcohol chains, synthesis and medical application thereof |
| 01/24/2012 | USRE43140 Immunoregulator |
| 01/24/2012 | US8101765 Process for preparing acyclic HCV protease inhibitors |
| 01/24/2012 | US8101729 Reacting polyoxyethylene glycol with lysine ; enantiomorphic pure product |
| 01/24/2012 | US8101712 Extracting impurities from broth having echinocandin compound with non polar water-immiscible organic solvent to obtain first two-phase system comprising aqueous phase and organic phase, removing organic phase, extracting echinocandin from aqueous phase with water-immiscible solvent |
| 01/24/2012 | US8101572 Methods for promoting wound healing and/or reducing scar formation |
| 01/24/2012 | US8101165 Use of immunogens to treat or prevent, in malignant tumors, the immune or vascular disorders induced by extracellular factors |
| 01/24/2012 | CA2455706C Novel method for synthesis of (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxylic acid derivatives and use for synthesis of perindopril |
| 01/24/2012 | CA2383300C Processes for the preparation of oxo-oxazoline or alloamino acid derivatives |
| 01/24/2012 | CA2295691C Methods and compositions for impairing multiplication of hiv-1 |
| 01/19/2012 | WO2012009336A1 Romidepsin solid forms and uses thereof |
| 01/19/2012 | WO2012009258A2 Peptidomimetic galanin receptor modulators |
| 01/19/2012 | WO2012007625A1 Compounds that can be used as systems for delivery across the blood-brain barrier, and delivery system/load constructs |
| 01/19/2012 | WO2012007562A1 Cyclotetrapeptides with pro-angiogenic properties |
| 01/19/2012 | WO2010082177A3 Compounds for cosmetic and dermopharmaceutical |
| 01/19/2012 | US20120015866 Prodrugs of Heteraromatic Compounds |
| 01/19/2012 | US20120014925 Self-Assembling Peptides Incorporating Modifications and Methods of Use Thereof |
| 01/19/2012 | CA2804795A1 Romidepsin solid forms and uses thereof |
| 01/18/2012 | EP2407478A1 New cyclotetrapeptides with pro-angiogenic properties |
| 01/18/2012 | EP2406634A2 Deuterium isobaric tag reagents for quantitative analysis |
| 01/18/2012 | EP2405944A1 Prodrugs |
| 01/18/2012 | CN102325785A Process for purifying lipopeptides |
| 01/18/2012 | CN102321153A Preparation method of xin'ao glycoside peptide powdery solid |
| 01/18/2012 | CN102321152A Cis-nitenpyram analogue containing glycylglycine, its preparation method and its application |
| 01/18/2012 | CN102321002A Cysteine derivatives as well as preparation method and application thereof |
| 01/17/2012 | US8097697 Tumor antigen protein SART-3 and tumor antigen peptides thereof |
| 01/17/2012 | US8097590 Melanocyte Stimulating Hormone; new peptides and peptidic conjugates containing at least 6 amino acids and including the sequence DPhe-Arg have a substantial activating effect on melanogenesis in the melanocytes of the hair bulb |
| 01/17/2012 | US8097589 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting mucous release into airways of patients; immunotherapy |
| 01/17/2012 | CA2276442C Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients |
| 01/12/2012 | WO2012006497A2 Mu opioid receptor agonist analogs of the endomorphins |
| 01/12/2012 | WO2012004554A1 Aldehyde compounds as inhibitors of dust mite group 1 peptidase allergen and their use |
| 01/12/2012 | WO2003085121A9 Nucleic acid and corresponding protein entitled 213p1f11 useful in treatment and detection of cancer |
| 01/12/2012 | US20120010158 Tumor necrosis factor inhibiting peptides and uses thereof |
| 01/12/2012 | US20120010147 Nmdar biomarkers for diagnosis and treatment of traumatic brain injury and other disorders |
| 01/12/2012 | CA2810170A1 Mu opioid receptor agonist analogs of the endomorphins |
| 01/11/2012 | EP1907015B1 Cancer treatment using viruses, fluoropyrimidines and camptothecins |
| 01/11/2012 | EP1438586B1 Fret protease assays for clostridial toxins |
| 01/11/2012 | CN102317307A Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions |
| 01/11/2012 | CN102317306A Hepatitis c virus inhibitors |
| 01/11/2012 | CN102316886A Skin aging-inhibiting peptide |
| 01/11/2012 | CN102311482A Aro-peptide and preparation method as well as medicinal combination and application of aro-peptide |
| 01/10/2012 | US8093353 Screening compounds which disrupt the association of helices with cytoplasmic membranes |
| 01/10/2012 | CA2398726C High purity lipopeptides, lipopeptide micelles and processes for preparing same |
| 01/05/2012 | WO2011115819A3 Small molecule inhibitors of muc1 and methods of identifying the same |
| 01/05/2012 | US20120004720 G-type peptides and other agents to ameliorate atherosclerosis and other pathologies |
| 01/05/2012 | US20120004180 Method of producing a novel opioid peptide |
| 01/05/2012 | US20120003692 Method for producing alpha-l-aspartyl-l-phenylalanine-beta-ester and method for producing alpha-l-aspartyl-l-phenylalanine-alpha-methyl ester |
| 01/05/2012 | US20120003673 Screening method, composition containing substance selected by the screening method, and binding substance |
| 01/05/2012 | US20120003229 Modulators of cytokine mediated signalling pathways and integrin alphavbeta3 receptor antagonists for combination therapy |
| 01/05/2012 | US20120003201 Vault agents for chronic kidney disease |
| 01/04/2012 | EP2402369A2 Peptide fragments for inducing synthesis of extracellular matrix proteins |
| 01/04/2012 | EP2402009A1 Inhibitors of serine protease, particularly hepatitis c virus NS3-NS4A protease, incorporating a fused ring system |
| 01/04/2012 | EP1863832B1 Age inhibitors |
| 01/04/2012 | EP1441720B1 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4a protease, incorporating a fused ring system |
| 01/04/2012 | CN102307890A Hepatitis c virus inhibitors |
| 01/04/2012 | CN102304169A Antihypertensive polypeptide and use thereof |
| 01/04/2012 | CN101607982B Fish skin collagen peptide with whitening effect and preparation process and application thereof |
| 01/03/2012 | US8088916 Hyaluronic acid-methotrexate conjugate |
| 01/03/2012 | US8088890 Peptides and peptidomimetic compounds, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| 01/03/2012 | US8088887 Nucleic acids, peptides, and antibodies for use in diagnosis and therapy; macular degeneration; cancers of the colon, breasts, prostate, liver, pancreas, and mouth; receptor binding assays of the peptide to neovasulatures |
| 01/03/2012 | US8088886 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 01/03/2012 | US8088741 Compounds for enzyme inhibition |
| 01/03/2012 | US8088733 Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disorders |
| 01/03/2012 | US8088390 Methods for the early diagnosis of ovarian cancer |
| 01/03/2012 | CA2425558C Lactam compound |
| 12/29/2011 | WO2011163398A2 Biomimetic peptides for bone augmentation |
| 12/29/2011 | WO2011114071A3 Synthetic cyclopeptide, preparation process and uses |
| 12/29/2011 | WO2011097633A3 Egf receptor mimicking peptides |
| 12/29/2011 | US20110319592 Process for the Purification of Antibodies Using Affinity Resins Comprising Specific Ligands |
| 12/29/2011 | US20110319493 Histone deacetylases, and uses related thereto |
| 12/29/2011 | US20110319347 Antioxidant agent |
| 12/29/2011 | US20110319293 Synthetic protease substrates, assay methods using such substrates and kits for practicing the assay |
| 12/29/2011 | US20110319274 Identification of Compounds Modifying a Cellular Response |
| 12/29/2011 | US20110318832 Human Telomerase Catalytic Subunit |
| 12/29/2011 | US20110318770 Compositions, kits and methods for determining plasmin activity |
| 12/29/2011 | CA2796894A1 Amide based glucagon superfamily peptide prodrugs |
| 12/29/2011 | CA2796879A1 Dipeptide linked medicinal agents |
| 12/28/2011 | EP2400295A1 Evaluation peptide for use in quantification of protein using mass spectrometer, artificial standard protein, and method for quantifying protein |
| 12/28/2011 | EP2399599A2 Mucin hypersecretion inhibitors and methods of use |
| 12/28/2011 | EP2398817A1 Process for purifying lipopeptides |
| 12/28/2011 | CN102300871A Hcv ns3蛋白酶抑制剂 Hcv ns3 protease inhibitors |
| 12/28/2011 | CN102297798A 朊病毒蛋白配基和使用方法 Prion protein ligands and methods of use |